Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neovac 2 Burkina Faso: Impact of the Integration of Hepatitis B Birth Dose Vaccine Into the Infant Immunization Schedule: a Mixed Methods Study Including a Cluster-randomized Trial, an Anthropological Study and an Economic Evaluation

NCT04029454 is registered in ClinicalTrials.gov with Institut Pasteur as lead sponsor.

NCT NCT04029454
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04029454 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neovac 2 Burkina Faso: Impact of the Integration of Hepatitis B Birth Dose Vaccine Into the Infant Immunization Schedule: a Mixed Methods Study Including a Cluster-randomized Trial, an Anthropological Study and an Economic Evaluation
Lead sponsor
Institut Pasteur
Phase
Not applicable
Overall status
Completed
Start date
October 19, 2020
Completion date
December 15, 2023
Enrollment
10,000 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b